(EYPT) Eyepoint Pharmaceuticals Renko charts technical analysis
(EYPT) Eyepoint Pharmaceuticals Renko charts technical analysis Renko analysis of Eyepoint Pharmaceuticals | Buy/Sell Eyepoint Pharmaceuticals
Eyepoint Pharmaceuticals trades in USA in Capital Goods sector.
10 day averaged volume of Eyepoint Pharmaceuticals is 1012590
| Date | Closing Price | Open | High | Low | Volume |
| 09 Wed Apr 2025 | 4.57 | 4.02 | 4.89 | 3.91 | 1.356 Mn |
| 08 Tue Apr 2025 | 4.13 | 4.79 | 4.86 | 4.09 | 1.085 Mn |
| 07 Mon Apr 2025 | 4.62 | 4.50 | 4.72 | 4.19 | 1.24 Mn |
| 04 Fri Apr 2025 | 4.61 | 5.10 | 5.10 | 4.51 | 1.597 Mn |
| 03 Thu Apr 2025 | 4.99 | 5.02 | 5.13 | 4.83 | 0.93 Mn |
| 02 Wed Apr 2025 | 5.37 | 5.00 | 5.42 | 4.92 | 1.083 Mn |
| 01 Tue Apr 2025 | 5.05 | 5.36 | 5.39 | 5.00 | 0.861 Mn |
| 31 Mon Mar 2025 | 5.42 | 5.63 | 5.71 | 5.34 | 0.638 Mn |
| 28 Fri Mar 2025 | 5.83 | 5.90 | 6.10 | 5.82 | 0.37 Mn |
| 24 Mon Mar 2025 | 6.34 | 6.36 | 6.69 | 6.22 | 1.199 Mn |
Indicators analysis of Eyepoint Pharmaceuticals (EYPT)
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eyepoint Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Eyepoint Pharmaceuticals in short term and the sell signal is strong.
Eyepoint Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Eyepoint Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Eyepoint Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5 and Eyepoint Pharmaceuticals (EYPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyepoint Pharmaceuticals (EYPT) stock. Volume based technical analysis of Eyepoint Pharmaceuticals (EYPT) stock is negative.
Eyepoint Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eyepoint Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Eyepoint Pharmaceuticals in short term and the sell signal is strong.
Eyepoint Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Eyepoint Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Eyepoint Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5 and Eyepoint Pharmaceuticals (EYPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyepoint Pharmaceuticals (EYPT) stock. Volume based technical analysis of Eyepoint Pharmaceuticals (EYPT) stock is negative.
Eyepoint Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.